Antimicrobial activities of hydrophobic 2-arylbenzofurans and an isoflavone against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus

Planta Medica

Volumn 70, Issue 7, 2004, Pages 685-687

  Fukai, Toshio ^a   Oku, Yukio ^b   Hano, Yoshio ^a   Terada, Sumio ^b  

^a TOHO UNIVERSITY   (Japan)

^b ZENYAKU KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; ISOFLAVONE; LINEZOLID; METICILLIN; VANCOMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BENZOFURANS; ENTEROCOCCUS; GLYCYRRHIZA URALENSIS; HUMANS; ISOFLAVONES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 3543038881     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-827196     Document Type: Article

References (17)

1. Borgen K, Sorum M, Wasteson Y, Kruse H. VanA-type vancomycin-resistant enterococci (VRE) remain prevalent in poultry carcasses 3 years after avoparcin was banned. Int J Food Microbiol 2001; 64: 89-94
2. Casewell M, Friis C, Marco E, McMullin P, Phillips I. The European ban on growth-promoting antibiotics and emerging consequences for hushy; man and animal health. J Anrimicrob Chemother 2003; 52: 159-61
3. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51: 11113-21
4. Kauffman CA. Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections. J Antimicrob Chemother 2003; 51: 11123-30
5. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. Antimicrobial activity of licorice flavonoids against methicillin-resistant Staphylococcus aureus. Fitoterapia 2002; 73: 536-9
6. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci 2002; 71: 1449-63
7. Shi Y-Q, Fukai T, Sakagami H, Chang W-J, Yang P-Q, Wang F-P, Nomura T. Cytotoxic flavonoids with isoprenoid groups from Mrums mongolica. J Nat Prod 2001; 64: 181-8
8. a) Fukai T, Hano Y, Hirakura K, Nomura T, Uzawa J, Fukushima K. Constituents of the cultivated mulberry tree. 25. Structures of two natural hypotensive Diels-Alder type adducts, mulberrofurans F and G, from the cultivated mulberry tree (Morus Ihou Koidz.). Chem Pharm Bull 1985; 33: 3195-204;
9. b) Hano Y, Miyagawa Y, Yano M, Nomura T. Correlation between albanol B and mulberrofuran I, and structure of mulberrofuran S, novel 2-arylbenzofuran derivative. Heterocycles 1989; 28: 745-50
10. Shimazaki M, Hano Y, Nomura T. Studies on Morus bombycis callus cultures. Natural Medicines (Tokyo) 2000; 54: 346-9
11. Salvatore MJ, King AB, Graham AC, Onishi HR, Bartizal KF, Abruzzo GK et al. Antibacterial activity of lonchocarpol A. J Nat Prod 1998; 61: 640-2
12. Tanaka H, Sato M, Fujiwara S, Hirata M, Etoh H, Takeuchi H. Antibacterial activity of isoflavonoids isolated from Erythrina variegata against methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol 2002; 35: 494-8
13. Hori S. Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Nippon Rinsho 2002; 60: 2144-9
14. Fukai T, Pei Y-H, Nomura T, Xu C-Q, Wu L-J, Chen Y-J. Components of the root bark of Morus cathayana. 1. Structures of five new isoprenylated flavonoids, sanggenols A-E and a diprenyl-2-arylbenzofuran, mulberrofuran V. Heterocycles 1996; 43: 425-36
15. Japan Society of Chemotherapy Working Party. Re-revised assay method of minimum inhibitory concentration. Chemotherapy 1981; 29: 76-9
16. Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ, and the NAVRESS Group. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). J Antimicrob Chemother 2003; 52: 382-8
17. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124: 1789-97